Top Suppliers:I want be here

1150701-66-8

1150701-66-8 structure
1150701-66-8 structure

Name SCD inhibitor 1
Synonyms 1H-1,2,3-Triazole-4-carboxamide, 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-
1-(3,4-Dichlorobenzyl)-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide
Description SCD inhibitor 1 is a stearoyl-coa desaturase (SCD) extracted from patent WO/2009060053 A1, compound example 16.
Related Catalog
Target

Stearoyl-CoA Desaturase (SCD)[1]

In Vitro SCD inhibitor 1 is a stearoyl-coa desaturase (SCD), which can be used to treat and/or preventing various diseases, including those mediated by SCD enzyme, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming Aβ42 peptide such as Alzheimer's disease[1].
References

[1]. Anne Marie Jeanne Bouillot, et al. 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors . PCT Int. Appl. (2009), WO 2009060053 A1 20090514.

Density 1.4±0.1 g/cm3
Molecular Formula C18H16Cl2N4O2
Molecular Weight 391.251
Exact Mass 390.065033
LogP 2.13
Index of Refraction 1.665